Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H2, 2015

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Table Of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Premenstrual Dysphoric Disorder (PMDD) to Women's Health Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Premenstrual Dysphoric Disorder (PMDD) to Women's Health Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Disclaimer 50
Source 50

List Of Tables
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Premenstrual Dysphoric Disorder (PMDD) to Women's Health Clinical Trials, G7 Countries (%), 2015* 14
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Premenstrual Dysphoric Disorder (PMDD) to Women's Health Clinical Trials, E7 Countries (%), 2015* 17
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Premenstrual Dysphoric Disorder (PMDD) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Premenstrual Dysphoric Disorder (PMDD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29